For the past 5 years there has been an exponential increase in the use of cocaine, phenylcyclidine hydrochloride (PCP), and other central nervous system (CNS) active drugs. A significant amount of this accelerated usage is in sexually active females, resulting in some urban hospitals reporting positive drug screens in over 16% of the infants born on their busy obstetrical service. There is a growing body of data showing that fetal exposure to cocaine, phenylcyclidine hydrochloride (PCP), and other CNS-active drugs results in infants and children with abnormal brain wave patterns, short-term neurologic signs, depression of interactive behavior, and poor organizational responses to environmental stimuli. Whether such neurologic findings will translate into a significant number of children with learning and behavioral problems needs to be the focus of long-term longitudinal studies of children with fetal drug exposure to cocaine, PCP, and other CNS-active drugs.
Get full access to this article
View all access options for this article.
References
1.
Adams, E.H., & Durell, J. (1984). Cocaine: A growing public health problem in cocaine. Pharmacology, effects and treatment of abuse. National Institutes of Drug Abuse Research Monograph, 50, pp. 9–14.
2.
American Academy of Pediatrics. (1988). Cocaine emergency. American Academy of Pediatric News, 14(5), 3.
3.
Bingol, N., Fuchs, M., Diaz, V., Stone, R.K., & Gromisch, D.S. (1987). Teratogenicity of cocaine in humans. Journal of Pediatrics, 110, 93–96.
4.
Bleyer, M.A., An, W.Y., Lange, W.A., & Raisz, L.G. (1970). Studies on the detection of adverse drug reactions in the newborn, I. Fetal exposure to maternal medications. Journal of the American Medical Association, 213, 2046–2048.
5.
Chasnoff, I.J. (1985). Effects of maternal narcotics versus non-narcotic addiction on neural behavior and infant development in current research on the consequences of maternal drug abuse. National Institutes of Drug Abuse Research Monograph, 59, 84–95.
6.
Chasnoff, I.J., Burns, W.J., Schnoll, S.H., & Burns, K.A. (1985). Cocaine use in pregnancy. New England Journal of Medicine, 313, 666–669.
7.
Chasnoff, I.J., Hatcher, R., Burns, W.J., & Schnoll, S.H. (1983). Pentazoine and tripelennanine (Ts and blues): Effects on fetus and neonate. Developmental Pharmacology and Therapeutics, 6, 162–169.
8.
Clarren, S.K., & Smith, D.W. (1978). The fetal alcohol syndrome. New England Journal of Medicine, 298, 1063–1067.
9.
Colliver, J. (1987). A decade of dawn: Cocaine related cases, 1976–1985. Washington DC: National Institute on Drug Abuse, Division of Epidemiological and Statistical Publications.
10.
Dixon, S.D., Coen, R.W., & Crutchfield, S. (1987). Visual dysfunction in cocaine exposed infants. Pediatric Research, 21, 359A.
11.
Doberczak, T.M., Shanzer, S., Senie, R.T., & Kandall, S.R. (1988). Neonatal neurologic and electroencephalographic effects of intrauterine cocaine exposure. Journal of Pediatrics, 113, 354–358.
12.
Donovan, J.E., & Jessor, R. (1978). Adolescent problem: Drinking. Journal of Studies of Alcohol, 39, 1506–1524.
13.
Gold, M.S. (1987). Crack abuse: Its implications and outcomes. Resident & Staff Physician, 33(8), 45–53.
14.
Gold, S., & Sherry, L. (1984). Hyperactivity, learning disabilities, and alcohol. Journal of Learning Disabilities, 17, 3–6.
15.
Goldman, A.S. (1980). Drugs and pregnancy. In S.J. Jaffe (Ed.), Pediatric pharmacology (pp. 101–118. New York: Grune & Stratton.
16.
Hill, R.M. (1973). Drugs ingested by the pregnant woman. Clinical Pharmacology and Therapeutics, 14, 654–659.
17.
Hill, L.M., & Kleinberg, F. (1984). Effects of drugs and chemicals on the fetus and newborn. Mayo Clinical Proceedings, 59, 707.
18.
Hill, R.M., & Tennyson, L.M. (1986). Maternal drug therapy: Effect on fetal and neonatal growth and neurobehavior. Neurotoxicology, 7, 121–139.
19.
Howard, J. (1986, April). Effects of phenylcyclidine hydrochloride on the neonate, perinatal effects of drugs of abuse. In M.D. Braudeet al., Symposium Summary [presented to] American Society for Pharmacology and Experimental Therapeutics, 2446–2453.
20.
Johnston, L.C., O'Malley, P.M., & Bachman, J.G. (1985). Use of illicit drugs by American high school students, 1975–1984. Rockville, MD: U.S. Department of Health and Human Services, National Institute on Drug Abuse.
21.
Johnston, L.C., O'Malley, P., & Bachman, J.G. (1986). Drug use among American high school students, college students, and other young adults. Rockville, MD: U.S. Department of Health and Human Services, National Institute on Drug Abuse.
22.
Jordan, R.L., Young, T.R., Dinwiddie, S.H., & Harry, G.J. (1979). Phenylcyclidine induced morphologic and behavioral alterations in the neonatal rat. Pharmacology, Biochemistry & Behavior, 11, 39–45.
23.
Kandel, D. (1986). Epidemiologic and psychosocial perspective on adolescent drug use. Journal of the American Academy of Child Psychiatry, 21, 328–347.
24.
Le Blanc, P.E., Parekh, A.J., Naso, B., & Glass, L. (1987). Effects of intrauterine exposure to alkaloidal cocaine (‘crack’). American Journal of Diseases of Children, 141, 937–938.
25.
MacDonald, D.I. (1987). Patterns of alcohol and drug use among adolescents. Pediatric Clinics of North America, 34, 275–288.
26.
National Institute on Drug Abuse, Division of Epidemiological and Statistical Publication (1987). Cocaine client admissions 1976–1985. Washington DC, DHHS Publication No. (ADM) 17–1528.
27.
Nicholas, J.M., & Schreiber, E.C. (1983). Phenylcyclidine exposure and the developing mouse: Behavior teratologic implications. Teratology, 28, 319–326.
28.
Nora, J.J., Nora, A.H., Somerville, P.T., Hill, R.M., & McNamara, D.G. (1967). External exposure to potential teratogens. Journal of American Medical Association, 202, 1065–1069.
29.
Oro, A.S., & Dixon, S. (1987). Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates. Journal of Pediatrics, 111, 571–578.
30.
Peckham, C., & King, R.W. (1963). A study of intercurrent conditions observed in pregnancy. American Journal of Obstetrics and Gynecology, 87, 609–624.
31.
Perry, B., Pesavento, D., Kussie, P., U'Prichard, D.C., & Schnoll, H. (1984). Prenatal exposure to drugs of abuse in humans: Effects on placental and neurotransmitter receptors. Neurobehavioral Toxicology and Teratology, 6, 295–301.
32.
Pinkert, T.M. (1985). Current research on the consequences of maternal drug abuse. NIDA Research Monograph, 59, 84–95.
33.
Pollin, W. (1985). The danger of cocaine. Journal of the American Medical Association, 254, 98.
34.
Rachal, J.V., Guess, L., Hubbard, R., & Maisto, S.A. (1982). Alcohol misuse by adolescents. Alcohol Health Research World, 6(3), 61–75.
35.
Schulze, B. (1987). Drug overdoses. Drug Bulletin of the County of Los Angeles Health Services, 11, 1.
36.
Schwartz, R.H., Hoffmann, N.G., Smith, D., Hayden, G.F., & Riddile, M. (1987). Use of phenylcyclidine among adolescents attending a suburban drug treatment facility. Journal of Pediatrics, 110, 322–324.
37.
Singer, M.I., Petchers, M.K., & Anglin, T.M. (1987). Detection of adolescent substance abuse in a pediatric outpatient department: A double-blind study. Journal of Pediatrics, 111, 938–941.
38.
Spohr, H.L., & Steinhausen, H.C. (1987). Follow-up studies of children with fetal alcohol. Neuro-pediatrics, 18, 13–17.
Streissguth, A.P.Clarren, S.K., & Jones, K.L. (1985, July 13). Natural history of the fetal alcohol syndrome: A ten year follow-up of 11 patients. Lancet, 2(8446), 85–91.
41.
Tarr, J.E., & Macklin, M. (1987). Cocaine. Pediatric Clinics of North America, 34, 319–331.
42.
Wish, E., Anderson, K., Miller, T., & Johnson, V. (1984). Drug use and abuse in arrestees: A new finding from a study of arrestees in Manhattan. Paper presented at the Annual Meeting of the Academy of Criminal Science, Chicago.
